The review also found that daily use of medical cannabis — especially inhaled or high-potency products — may increase the risk of cardiovascular problems compared with occasional use. That includes a higher chance of heart attack, stroke and coronary artery disease.

Researchers found a chasm between the health reasons for which the public seeks out cannabis and what gold-standard science actually shows about its effectiveness.

President Donald Trump has voiced support for reclassifying cannabis and making it a legally obtainable drug -- possibly as soon as next week.

California’s state government was handed an embarrassing court loss Tuesday after an Orange County judge ruled that the Department of Cannabis Control, or DCC, failed to comply with its own laws designed to stop illegal cannabis from leaving the state.

Aurora Cannabis ( ACB +14.72%) stock leapt 14.5% "higher" (get it? Marijuana? High?) through 11:55 a.m. ET Friday on some positive marijuana news out of the White House. As The Washington Post reports, President Trump wants to legalize marijuana (sort of), and marijuana investors are overjoyed at the prospect.

Tilray Brands and Canopy Growth jumped more than 40 per cent in New York trading. A specialist fund, the Amplify Seymour Cannabis ETF, rallied around 51 per cent, putting it on track for its best day on record. Yet even with Friday’s spike, the ETF is still heading for its fifth straight annual loss.

The Post Dispensary in Beaver Dam becomes Kentucky's first fully-licensed medical marijuana facility, with Gov. Beshear sharing opening photos on social media

Nearly $57 million in illegal cannabis was seized during enforcement operations that took place in the Bay Area and Southern California last month, state officials said.

Major cannabis ETFs recorded their best-ever weekly gains on Friday after media reports indicated that President Donald Trump will soon issue an executive order to reclassify marijuana as a less dangerous drug,